Vincerx Pharma Inc. (VINC)
0.15
-0.02 (-12.13%)
At close: Jan 15, 2025, 3:59 PM
0.15
-0.13%
After-hours Jan 15, 2025, 07:55 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -40.16M | -65.37M | -39.31M | -10.72M | -54.00K |
| Depreciation & Amortization | 915.00K | 939.00K | 340.00K | 20.00K | n/a |
| Stock-Based Compensation | 3.56M | 10.06M | 23.31M | 4.38M | 1.20K |
| Other Working Capital | -2.95M | -2.07M | 4.08M | -1.42M | 10.80K |
| Other Non-Cash Items | -583.00K | -6.59M | -23.36M | 5.02M | 42.00K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -4.19M | -1.02M | 5.61M | -959.00K | 10.80K |
| Operating Cash Flow | -40.45M | -59.60M | -33.40M | -2.28M | -35.00K |
| Capital Expenditures | n/a | n/a | -5.26M | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -11.82M | -42.98M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 53.32M | 2.40M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -40.58K | -5.00M | -65.64M | -65.64M |
| Investing Cash Flow | 41.50M | -40.58M | -5.26M | -65.64M | -65.64M |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 114.00K | 280.00K | 41.02M | 64.07M | 66.46M |
| Financial Cash Flow | 114.00K | 280.00K | 88.45M | 64.07M | 66.46M |
| Net Cash Flow | 1.12M | -99.83M | 49.77M | 61.79M | 790.04K |
| Free Cash Flow | -40.45M | -59.60M | -38.66M | -2.28M | -35.00K |